09:45 EDT EyePoint Pharmaceuticals trading resumes
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EYPT:
- EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU™ in Non-Proliferative Diabetic Retinopathy
- Fly Insider: Zura Bio, Google among week’s notable insider trades
- EYPT Earnings this Week: How Will it Perform?
- EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- EyePoint reports inducement grants under Nasdaq listing rule
Questions or Comments about the article? Write to editor@tipranks.com